Filing Details
- Accession Number:
- 0001127602-13-000811
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-03 17:18:19
- Reporting Period:
- 2013-01-02
- Filing Date:
- 2013-01-03
- Accepted Time:
- 2013-01-03 17:18:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218713 | Robert Cascella | 35 Crosby Drive Bedford MA 01730 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-01-02 | 21,985 | $1.92 | 422,640 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-02 | 21,985 | $20.40 | 400,655 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2013-01-02 | 21,985 | $0.00 | 21,985 | $1.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,984 | 2004-02-17 | 2013-02-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 783 | Indirect | By Spouse |
Footnotes
- The transaction reported herein was made pursuant to a written trading plan adopted in accordance with SEC Rule 10b5-1 on May 8, 2012.
- The price reported herein reflects a weighted average sale price. Actual sale prices ranged from $20.29 to $20.435, inclusive. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.